logo

This website uses cookies to ensure you get the best experience on our website.

Read through our Privacy Policy to learn more.

 Go Back

Myriad: Q4 Earnings Snapshot

By AP News - Feb 24, 2025, 05:12 PM ET
Last Updated - Feb 24, 2025, 05:12 PM EST
Myriad: Q4 Earnings Snapshot

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Myriad Genetics Inc. (MYGN) on Monday reported a loss of $42.5 million in its fourth quarter.

On a per-share basis, the Salt Lake City-based company said it had a loss of 47 cents. Earnings, adjusted for one-time gains and costs, came to 3 cents per share.

Sponsored

The results met Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was also for earnings of 3 cents per share.

The molecular diagnostic company posted revenue of $210.6 million in the period.

For the year, the company reported a loss of $127.3 million, or $1.41 per share. Revenue was reported as $837.6 million.

For the current quarter ending in March, Myriad expects its results to range from a loss of 8 cents per share to a loss of 4 cents per share.

The company said it expects revenue in the range of $196 million to $204 million for the fiscal first quarter.

Myriad expects full-year earnings in the range of 7 cents to 11 cents per share, with revenue ranging from $840 million to $860 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MYGN at https://www.zacks.com/ap/MYGN

Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250415